Clinical Trial: Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT04643093) titled 'Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia' on Nov. 22.

Brief Summary: The study is to evaluate whether the efficacy of 1PC111 is superior to pitavastatin and ezetimibe in patients with primary hypercholesterolemia or mixed dyslipidemia in the 12 week treatment period.

Study Type: Interventional

Condition: * Primary Hypercholesterolemia

* Mixed Dyslipidemias

Intervention: * Drug: Pitavastatin

Pitavastatin, QD

* Drug: Ezetimibe

Ezetimibe, QD

* Drug: 1PC111

1PC111, QD

Recruitment Status: Recruiting

Sponsor: Orient Pharma Co., ...